{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:50:17Z","timestamp":1792068617396,"version":"4.4.0"},"reference-count":45,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"DOI":"10.1080\/17425247.2026.2748106","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:21:52Z","timestamp":1791796912000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["\u2018Harmful\u2019 or \u2018excipients of concern\u2019? Rethinking terminology and risk in pediatric excipients"],"prefix":"10.1080","author":[{"given":"Eleanor","family":"Dakin","sequence":"first","affiliation":[{"name":"Independent Researcher","place":["Calgary, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlin","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Costa","family":"Vicente Silva","sequence":"additional","affiliation":[{"name":"Fagron BV","place":["Rotterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpakumari","family":"Chavda","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt., Ltd","place":["Hyderabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiee","family":"Allen","sequence":"additional","affiliation":[{"name":"Colorcon","place":["Dartford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Salunke","sequence":"additional","affiliation":[{"name":"European Paediatric Formulation Initiative (EUPFI), University College London School of Pharmacy","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"EMA [Internet]. Questions and answers on benzyl alcohol used as an excipient in medicinal products for human use. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-answers-benzyl-alcohol-used-excipient-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_4_1","unstructured":"EMA [Internet]. Assessment report propylene glycol in medicinal products for children International non-proprietary name: propylene glycol article 5(3) of regulation (EC) no 726\/2004. Procedure No. EMEA\/H\/A-5(3)\/1317. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2014 Mar 20 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/opinion-any-scientific-matter\/assessment-report-article-53-procedure-propylene-glycol-medicinal-products-children_en.pdf"},{"key":"e_1_3_5_5_1","unstructured":"EMA [Internet]. Questions and answers on benzoic acid and benzoates used as excipients in medicinal products for human use. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-and-answers-benzoic-acid-and-benzoates-used-excipients-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_6_1","unstructured":"EMA [Internet]. Questions and answers on ethanol in the context of the revision of the guideline on \u2018Excipients in the label and package leaflet of medicinal products for human use\u2019 (CPMP\/463\/00). London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2014 Jan 23 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-and-answers-ethanol-context-revision-guideline-excipients-label-and-package-leaflet-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2002.1542"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2018.5047"},{"key":"e_1_3_5_9_1","unstructured":"EMA [Internet]. Questions and answers on boric acid in the context of the revision of the guideline on \u2018Excipients in the label and package leaflet of medicinal products for human use\u2019 (CPMP\/463\/00 Rev. 1). London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2015 Jul 23 [cited 2026 May 24]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-questions-answers-boric-acid-context-revision-guideline-excipients-label-package-leaflet_en.pdf"},{"key":"e_1_3_5_10_1","unstructured":"EMA [Internet]. Questions and answers on benzalkonium chloride used as an excipient in medicinal products for human use. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-answers-benzalkonium-chloride-used-excipient-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_11_1","unstructured":"EMA [Internet]. Questions and answers on sodium laurilsulfate used as an excipient in medicinal products for human use. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-answers-sodium-laurilsulfate-used-excipient-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_12_1","unstructured":"EMA [Internet]. Cyclodextrins used as excipients: report published in support of the \u2018Questions and answers on cyclodextrins used as excipients in medicinal products for human use\u2019 (EMA\/CHMP\/495747\/2013). London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/questions-answers-cyclodextrins-used-excipients-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114458"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.09.013"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.05.004"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2020.12.021"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/02652039809374617"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11647-x"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0277-6"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2016-001107"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2024.2327462"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004340"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-020-1956-x"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-021-00208-9"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4486-7"},{"issue":"1","key":"e_1_3_5_26_1","first-page":"A220","article-title":"5PSQ-121 a review of the exposure to potentially harmful excipients through oral liquid forms in paediatric inpatients in France","volume":"31","author":"Bobillot M","year":"2024","unstructured":"Bobillot M, Delannoy V, Trouillard A, et al. 5PSQ-121 a review of the exposure to potentially harmful excipients through oral liquid forms in paediatric inpatients in France. Eur J Hosp Pharm. 2024;31(Suppl 1):A220.","journal-title":"Eur J Hosp Pharm"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0551-8"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-025-03474-1"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm89030032"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-12-136"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.72.e164270"},{"issue":"1","key":"e_1_3_5_32_1","first-page":"A272","article-title":"5PSQ-152 do we know the content of harmful excipients in medicines that neonates receive?","volume":"26","author":"Nogu\u00e9 Pujadas E","year":"2019","unstructured":"Nogu\u00e9 Pujadas E, Aguilar Salmer\u00f3n R, D\u00edez Vallejo C, et al. 5PSQ-152 do we know the content of harmful excipients in medicines that neonates receive? Eur J Hosp Pharm. 2019;26(Suppl 1):A272.","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"e_1_3_5_33_1","article-title":"Harmful excipients for pediatric patients","volume":"39","author":"Clouser A","year":"2022","unstructured":"Clouser A, Diseroad E. Harmful excipients for pediatric patients. Contemp Pediatr. 2022;39(1).","journal-title":"Contemp Pediatr"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2022-NPPG.45"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-NPPG.56"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010119"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-014-2272-z"},{"key":"e_1_3_5_38_1","unstructured":"EMA [Internet]. Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use EMA\/CHMP\/SWP\/272921\/2012. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2015 Oct 22 [cited 2026 May 24]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-use-methyl-propylparaben-excipients-human-medicinal-products-oral-use_en.pdf"},{"key":"e_1_3_5_39_1","volume-title":"Handbook of pharmaceutical excipients","author":"Rowe RC","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London UK: Pharmaceutical Press and American Pharmacists Association; 2009.","edition":"6"},{"key":"e_1_3_5_40_1","unstructured":"EMA [Internet]. Information for the package leaflet regarding aspartame and phenylalanine used as excipients in medicinal products for human use EMA\/CHMP\/134648\/2015. London: European Medicines Agency Committee for Human Medicinal Products (CHMP); 2017 Oct 9 [cited 2026 Jul 6]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/information-package-leaflet-regarding-aspartame-and-phenylalanine-used-excipients-medicinal-products-human-use_en.pdf"},{"key":"e_1_3_5_41_1","unstructured":"FDA [Internet]. Aspartame and other sweeteners in food. US: FDA. 2025 Feb 27 [cited 2026 Jul 6]. Available from: https:\/\/www.fda.gov\/food\/food-additives-petitions\/aspartame-and-other-sweeteners-food"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/children9040453"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114447"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12950"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2017.165"},{"issue":"2","key":"e_1_3_5_46_1","first-page":"A5324","article-title":"Safe excipient exposure in neonates and small children - protocol for the SEEN project","volume":"64","author":"Valeur KS","year":"2017","unstructured":"Valeur KS, Hertel SA, Lundstr\u00f8m KE, et al. Safe excipient exposure in neonates and small children - protocol for the SEEN project. Dan Med J. 2017;64(2):A5324.","journal-title":"Dan Med J"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479017716713"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2748106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425247.2026.2748106","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2748106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:13:40Z","timestamp":1792066420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2026.2748106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":45,"alternative-id":["10.1080\/17425247.2026.2748106"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2026.2748106","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}